LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Antimicrobials Basilea's focus on developing novel broad-spectrum antifungal and antibiotic drugs presents opportunities to collaborate with healthcare providers, hospitals, and pharmacies seeking cutting-edge therapies for severe invasive infections.

Research Collaborations Their active partnership with companies like Phare Bio and Prokaryotics indicates a receptiveness to joint ventures, which could be leveraged to introduce new partnership or licensing opportunities with biotech and pharma firms.

Government Funding Access With recent funding of USD 25 million from BARDA, Basilea has demonstrated support for innovative antimicrobial research, suggesting potential avenues for government or public sector sales and grants for organizations aligned with their research.

Advanced Technology Use Utilization of AI in drug development shows Basilea's commitment to incorporating advanced tech for quickening drug discovery, providing a platform to offer complementary AI solutions or computational services for their R&D pipeline.

Expanding Portfolio Their focus on antifungal and antibacterial agents indicates potential sales opportunities in hospitals, infectious disease clinics, and pharmaceutical partners interested in expanding antimicrobial offerings with innovative solutions.

Basilea Pharmaceutica Tech Stack

Basilea Pharmaceutica uses 8 technology products and services including SAP FICO, Cloudflare, Microsoft Visio, and more. Explore Basilea Pharmaceutica's tech stack below.

  • SAP FICO
    Accounting
  • Cloudflare
    Content Management System
  • Microsoft Visio
    Dev Tools
  • Microsoft 365
    Email
  • Microsoft
    Miscellaneous
  • Java
    Programming Languages
  • Smartsheet
    Project Management
  • Microsoft Project
    Project Management

Media & News

Basilea Pharmaceutica's Email Address Formats

Basilea Pharmaceutica uses at least 1 format(s):
Basilea Pharmaceutica Email FormatsExamplePercentage
First.Last@basilea.comJohn.Doe@basilea.com
87%
LastF@basilea.comDoeJ@basilea.com
8%
Last.First@basilea.comDoe.John@basilea.com
4%
First.Middle@basilea.comJohn.Michael@basilea.com
1%

Frequently Asked Questions

Where is Basilea Pharmaceutica's headquarters located?

Minus sign iconPlus sign iconBasilea Pharmaceutica's main headquarters is located at 167b Hegenheimermattweg Allschwil, Basel-landschaft 4123 Switzerland. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Basilea Pharmaceutica's phone number?

Minus sign iconPlus sign icon You can contact Basilea Pharmaceutica's main corporate office by phone at
+1-978-533-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Basilea Pharmaceutica's official website and social media links?

Minus sign iconPlus sign iconBasilea Pharmaceutica's official website is basilea.com and has social profiles on LinkedInCrunchbase.

What is Basilea Pharmaceutica's SIC code NAICS code?

Minus sign iconPlus sign iconBasilea Pharmaceutica's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Basilea Pharmaceutica have currently?

Minus sign iconPlus sign iconAs of June 2026, Basilea Pharmaceutica has approximately 252 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: D. V.Ceo: A. M.Chief Technology Officer: G. H.. Explore Basilea Pharmaceutica's employee directory with LeadIQ.

What industry does Basilea Pharmaceutica belong to?

Minus sign iconPlus sign iconBasilea Pharmaceutica operates in the Biotechnology Research industry.

What technology does Basilea Pharmaceutica use?

Minus sign iconPlus sign iconBasilea Pharmaceutica's tech stack includes SAP FICOCloudflareMicrosoft VisioMicrosoft 365MicrosoftJavaSmartsheetMicrosoft Project.

What is Basilea Pharmaceutica's email format?

Minus sign iconPlus sign iconBasilea Pharmaceutica's email format typically follows the pattern of First.Last@basilea.com. Find more Basilea Pharmaceutica email formats with LeadIQ.

How much funding has Basilea Pharmaceutica raised to date?

Minus sign iconPlus sign icon As of June 2026, Basilea Pharmaceutica has raised $25M in funding. The last funding round occurred on Sep 16, 2025 for $25M.

When was Basilea Pharmaceutica founded?

Minus sign iconPlus sign iconBasilea Pharmaceutica was founded in 2000.

Basilea Pharmaceutica

Biotechnology ResearchBasel-landschaft, Switzerland201-500 Employees

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com.

Section iconCompany Overview

Headquarters
167b Hegenheimermattweg Allschwil, Basel-landschaft 4123 Switzerland
Phone number
+1-978-533-****
Website
basilea.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $25M

    Basilea Pharmaceutica has raised a total of $25M of funding over 8 rounds. Their latest funding round was raised on Sep 16, 2025 in the amount of $25M.

  • $10M$25M

    Basilea Pharmaceutica's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $25M

    Basilea Pharmaceutica has raised a total of $25M of funding over 8 rounds. Their latest funding round was raised on Sep 16, 2025 in the amount of $25M.

  • $10M$25M

    Basilea Pharmaceutica's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    D. V.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. H.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. K.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. E.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. E.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. K.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Assistant Chief Technology Officer, Technical Operations Department
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. K.
    Head Of Global Supply Chain Management
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.